NTLA vs VTI
Intellia Therapeutics Inc (NTLA) versus Vanguard Total Stock Market Index Fund ETF Shares (VTI) — a side-by-side from cached financials, not a winner call.
Intellia Therapeutics Inc (NTLA) is a biotechnology company listed on US.
Vanguard Total Stock Market Index Fund ETF Shares (VTI) common stock listed on US.
Latest reported NTLA revenue for 2026-06-30 was $22.7M. Net income was -$202.9M. Revenue was up 50.9% from 2026-03-31 to 2026-06-30. NTLA currently screens at market cap $1.19B.
VTI does not have a complete income-statement cache yet.
NTLA currently screens at market cap $1.19B. VTI currently screens at market cap $0.
Not investment advice. Open the NTLA and VTI stock pages for the full models.
Not investment advice.